Following our acquisition of ViraQuest in February 2024 we’re excited to share that we have fully transitioned all ViraQuest adenovirus manufacturing to our new facility in Davis, California.
Continued partnership with ViraQuest founders Richard Anderson and Ron Haskell.
This transition would not have been possible without the continued support of founders Richard Anderson and Ron Haskell who started ViraQuest in Iowa back in 2001. Over the past year our team has worked closely with Ron and Richard to ensure that we capture all of the methods they’ve developed over the past 20 + years and also a deep understanding of the different projects they have run for you.
We’re grateful to Ron and Richard for the opportunity to continue serving you and look forward to maintaining the legacy of customer-focused scientific support that has made ViraQuest an enduring name in the industry.
Brand new, state-of-the-art laboratory.
Our new facility in Davis, CA features dedicated cell culture suites for both naïve and adenoviral work in addition to over 3,000 square feet of laboratory space. We are excited to grow our business as Antibodies Inc continues to add product and service capabilities to better support our customers. You can find more information on our Adenovirus production services.
We're proud of our highly-skilled team, trained in adenovirus production.
The team in Davis includes Will Fry (President of Antibodies Inc), Shakur Mohibi (Scientific Director: Antibodies Inc) and scientists Kris Kralovich and Chris Lord-Lloyd. To ensure that all of the expertise and customer-specific knowledge gained by Richard and Ron over the past 20+ years remains accessible, Richard and Ron remain part of the team and continue to consult, train, and advise our team in Davis.
ViraQuest's dedication to excellence endures!
We’re excited to continue the tradition of customer-focused adenovirus development that Ron and Richard began with ViraQuest over 20 years ago and look forward to continuing to work with you as a partner in discovery and scientific advancement.